5-Fluorouracil/Leucovorin and arsenic trioxide for patients with refractory/relapsed colorectal carcinoma: A clinical experience

$5-Fluorouracil/Leucovorin and arsenic trioxide for patients with refractory/relapsed colorectal carcinoma: A clinical experience$

Journal article

Peer reviewed

Lisa Podolsky, Melissa Oh, Pochi R Subbarayan, Dido Francheschi, Alan Livingstone and Bach Ardalan

Acta oncologica, Vol.50(4), pp.602-605

2011-05

PMID: 20950119

Metrics

15 Record Views

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Citation topics: 1 Clinical & Life Sciences; 1.111 Liver & Colon Cancer; 1.111.557 Metastatic Colorectal Cancer
Web Of Science research areas: Oncology
ESI research areas: Clinical Medicine

This output has contributed to the advancement of the following goals:

Source: InCites

Title: 5-Fluorouracil/Leucovorin and arsenic trioxide for patients with refractory/relapsed colorectal carcinoma: A clinical experience
Creators: Lisa Podolsky - Division of Hematology and Oncology, Department of Medicine
Melissa Oh - Division of Hematology and Oncology, Department of Medicine
Pochi R Subbarayan - Division of Hematology and Oncology, Department of Medicine
Dido Francheschi - Department of Surgical Oncology, Miller School of Medicine, University of Miami, Miami, Florida, USA
Alan Livingstone - Department of Surgical Oncology, Miller School of Medicine, University of Miami, Miami, Florida, USA
Bach Ardalan - Division of Hematology and Oncology, Department of Medicine
Publication Details: Acta oncologica, Vol.50(4), pp.602-605
Publisher: Informa Healthcare
Academic Unit: Miller School of Medicine; UMMG Department of Surgery; UMMG Dept of Medicine - Hematology/Oncology; UMMG Dept of Surgery - Div of Surgical Oncology
Language: English
Resource Type: Journal article
PMID: 20950119
Record Identifier: 991031561250102976